Tradestie Institutional Equity Comparison Engine
IHE vs IHI โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
IHE Overall Edge
IHE Captures Institutional Edge (1โ1 Pillars ยท 3โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to iShares U.S. Pharmaceuticals ETF (IHE) driven by superior Momentum & Technical while IHI counters with relative strength in Options & Structure. Fundamentally, IHE trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus IHI at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, IHE sits in UNCLASSIFIED (5th %ile IV; Dealer Gamma Walls on Pro) against IHI sits in UNCLASSIFIED (3rd %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
IHE N/M vs IHI N/M Fwd P/E
Growth & Margin Winner
Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner
IHE
1Y +36.9% vs -8.4% ยท 52W Pos 93% vs 59%
Options & Structure Winner
IHI
UNCLASSIFIED (5th %ile IV) vs UNCLASSIFIED (3rd %ile IV)
IHE
NYSE Arca
iShares U.S. Pharmaceuticals ETF
Institutional Equity
$109.89
-1.03% 1D
Market Cap
N/A
1M Return
+8.74%
1Y Return
+36.93%
Forward P/E
N/M
Unified AI Score
39.6 / 100
SELL
Tech 24.0
Fund 37.0
Flow 50.0
Mom 40.0
IHI
NYSE Arca
iShares U.S. Medical Devices ETF
Institutional Equity
$57.66
-0.63% 1D
Market Cap
N/A
1M Return
+7.29%
1Y Return
-8.43%
Forward P/E
N/M
Unified AI Score
32.0 / 100
SELL
Tech 50.0
Fund 30.0
Flow 50.0
Mom 40.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
IHE +36.93%
IHI -8.43%
Spread: +45.36 pp (IHE Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
IHE TTM Op. Margin: N/A
IHI TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on IHE vs IHI. Trailing 12-month operating profitability (IHE N/A vs IHI N/A) and valuation multiples (IHE N/M vs IHI N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | IHE | IHI | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | N/A | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | N/A | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | N/A | N/A | Higher Margin | Tie |
| Net Profit Margin Profitability | N/A | N/A | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | N/A | N/A | Higher ROE | Tie |
| 52-Week Range Position Momentum | 93% ($80โ$112) | 59% ($47โ$65) | Stronger Trend | IHE |
| Beta / 30D Volatility Risk Regime | 0.40ฮฒ ยท 25% Vol | 0.41ฮฒ ยท 34% Vol | Lower Realized Risk | IHE |
| Unified Institutional Score Composite Signal | 39.6 / 100 (SELL) | 32.0 / 100 (SELL) | Higher Composite | IHE |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full IHE vs IHI Buy Guide
IHE
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
5th %ile
IV Regime
Compressed (<25th %ile)
IHI
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
3rd %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither IHE nor IHI registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.